Reports
-
Changes Made to States Medicaid Programs To Ensure Beneficiary Access to Prescriptions During the COVID-19 Pandemic
-
Minnesota Medicaid Managed Care Entities Used a Majority of Medicaid Funds Received for Medical Expenses and Quality Improvement Activities
-
Medicare Overpaid $636 Million for Neurostimulator Implantation Surgeries
-
Advisory Opinion 21-14
-
Advisory Opinion 21-13
-
High-expenditure Medicare drugs often qualified for Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases
-
Advisory Opinion 21-12
-
An Ophthalmology Clinic in Florida: Audit of Medicare Payments for Eye Injections of Avastin, Eylea, and Lucentis
-
Colorado Did Not Invoice Rebates to Manufacturers for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations
-
CMS COVID-19 Data Included Required Information From the Vast Majority of Nursing Homes, but CMS Could Take Actions To Improve Completeness and Accuracy of the Data
-
Medicare Beneficiaries Hospitalized With COVID-19 Experienced a Wide Range of Serious, Complex Conditions
-
Oklahoma Oversight of Medicaid Outpatient Services for Opioid Use Disorder Was Generally Effective
-
Medicare Home Health Agency Provider Compliance Audit: Catholic Home Care
-
Advisory Opinion 21-11
-
Medicare Hospital Provider Compliance Audit: Jewish Hospital
-
CGS Administrators, LLC, Claimed Some Unallowable Medicare Pension Costs Through Its Incurred Cost Proposals
-
CGS Administrators, LLC, Claimed Some Unallowable Medicare Supplemental Executive Retirement Plan III Costs Through Its Incurred Cost Proposals
-
Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the First Quarter of 2021
-
Medicare Paid New Hospitals Three Times More for Their Capital Costs Than They Would Have Been Paid Under the Inpatient Prospective Payment System
-
Missouri Claimed Federal Reimbursement for $3.4 Million in Payments to Health Home Providers That Did Not Meet Medicaid Requirements